Like CD44, RHAMM undergoes alternative splicing as truncated isoforms were detected in tumor cells [83], and it has been reported to be highly expressed in several tumors, including breast, colon, brain, prostate, and endometrial [84,85,86,87]. This evidence concerns the gene CD44 and neoplasm.